Perfusion CMR and SPECT in hypertrophic cardiomyopathy

International Journal of Cardiology

Volumn 129, Issue 1, 2008, Pages

  O'Hanlon, Rory ^a   Teo, Karen ^a   Bucciarelli Ducci, Chiara ^a,b   Pennell, Dudley J ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b National Heart and Lung Institute   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Coronary artery disease; Hypertrophic cardiomyopathy; Perfusion; SPECT

Indexed keywords

ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RELIABILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERFUSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 49349103387     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.06.089     Document Type: Article

References (3)

1. Cannon R.O., Dilsizian V., O'Gara P.T., et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 83 (1991) 1660-1667
2. Hachamovitch R.H.S., Cohen I., Germano G., et al. Inducible ischemia is superior to EF for identification of short term survival benefit with revascularisation vs medical therapy [abstract]. Circulation 106 (2002) II-523
3. 1Amano Y., Shinichiro K., Takayama M., et al. Comparison of contrast-enhanced MRI with iodine-123 BMIPP detection of myocardial damage in hypertrophic cardiomyopathy. AJR 185 (2005) 312-318